- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for Lpath Inc (HQ8A)
| Open: | 3.835 | Day's Range: | 3.835 - 3.835 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 3.799 | 52wk Range: | 0.056 - 5.222 | 1-Yr Rtn: | -6.67% |
Key Statistics for HQ8A
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.7900 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HQ8A
Company Profile & Key Executives for HQ8A
Lpath, Inc. is a drug discovery company with a focus on bioactive signaling lipids as targets for treating and diagnosing human diseases.
| Scott R PancoastPresident/CEO | Gary J G AtkinsonVP/CFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HQ8A News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page